Related references
Note: Only part of the references are listed.Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and Progression
Daniele Tavernari et al.
CANCER DISCOVERY (2021)
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer
Amit M. Oza et al.
CLINICAL CANCER RESEARCH (2020)
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Andriy Marusyk et al.
CANCER CELL (2020)
Induction of DNMT3B by PGE2 and IL6 at Distant Metastatic Sites Promotes Epigenetic Modification and Breast Cancer Colonization
Jae Young So et al.
CANCER RESEARCH (2020)
Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients
Kerry-Ann McDonald et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Intratumoral Heterogeneity: More Than Just Mutations
Kunihiko Hinohara et al.
TRENDS IN CELL BIOLOGY (2019)
Perioperative Use of Nonsteroidal Anti-inflammatory Drugs Decreases the Risk of Recurrence of Cancer After Colorectal Resection: A Cohort Study Based on Prospective Data
Anders Schack et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases
Dipak Panigrahy et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies
Lindsay Angus et al.
NATURE GENETICS (2019)
Pan-cancer whole-genome analyses of metastatic solid tumours
Peter Priestley et al.
NATURE (2019)
Non-Genetic Intra-Tumor Heterogeneity Is a Major Predictor of Phenotypic Heterogeneity and Ongoing Evolutionary Dynamics in Lung Tumors
Anchal Sharma et al.
CELL REPORTS (2019)
Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models
Ioanna Keklikoglou et al.
NATURE CELL BIOLOGY (2019)
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors
Charles Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The DNA methyltransferase family: a versatile toolkit for epigenetic regulation
Frank Lyko
NATURE REVIEWS GENETICS (2018)
Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
Charissa Kim et al.
CELL (2018)
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
Katherine A. Hoadley et al.
CELL (2018)
DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine
Jia Yu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy
Jordan A. Krall et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity
Emelie Berglund et al.
NATURE COMMUNICATIONS (2018)
Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis
Mohammed L. Ibrahim et al.
CELL REPORTS (2018)
The Drug Repurposing Hub: a next-generation drug library and information resource
Steven M. Corsello et al.
NATURE MEDICINE (2017)
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
Nathan C. Sheffield et al.
NATURE MEDICINE (2017)
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism
George S. Karagiannis et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
Laxmi Silwal-Pandit et al.
CLINICAL CANCER RESEARCH (2017)
Genomic Evolution of Breast Cancer Metastasis and Relapse
Lucy R. Yates et al.
CANCER CELL (2017)
Surgery for Cancer: A Trigger for Metastases
Samer Tohme et al.
CANCER RESEARCH (2017)
Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
Noemi Andor et al.
NATURE MEDICINE (2016)
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V
Marco Colleoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Targeting the cancer epigenome for therapy
Peter A. Jones et al.
NATURE REVIEWS GENETICS (2016)
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
DNMT3B isoforms without catalytic activity stimulate gene body methylation as accessory proteins in somatic cells
Christopher E. Duymich et al.
NATURE COMMUNICATIONS (2016)
DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR
Goran Micevic et al.
CELL REPORTS (2016)
Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients
Jonine D. Figueroa et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation
Tuncay Baubec et al.
NATURE (2015)
Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery
P. Forget et al.
BRITISH JOURNAL OF ANAESTHESIA (2014)
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Xiaojing Yang et al.
CANCER CELL (2014)
A Comprehensive DNA Methylation Profile of Epithelial-to-Mesenchymal Transition
F. Javier Carmona et al.
CANCER RESEARCH (2014)
Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
Hariharan Easwaran et al.
MOLECULAR CELL (2014)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
Christos Hatzis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer
Christina Yau et al.
BREAST CANCER RESEARCH (2010)
DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer
Katsuhiko Nosho et al.
CLINICAL CANCER RESEARCH (2009)
Genes that mediate breast cancer metastasis to the brain
Paula D. Bos et al.
NATURE (2009)
Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing
Heinz G. Linhart et al.
GENES & DEVELOPMENT (2007)
Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors
Kim Appleton et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
SD Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
I Rhee et al.
NATURE (2002)
Share Paper
